Silver Book Fact

Resonable disease prevention and management efforts could add $5.7 trillion to the nation’s economic output by 2050– a boost of 18%.

Milken Institute. The Economic Burden of Chronic Disease on the United States; http://www.chronicdiseaseimpact.com/state_sheet/USA.pdf

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • New Medicines Account for 40% of Increase in Life Expectancy  
  • Each new drug approved between 1970 and 1991 saves an average of 11,200 life-years in 1991.  
  • Decline in Disability Rates for People Aged over 65 Years, 1982-2000  
  • Using newer drugs could lower overall health expenses by as much as $111 per person, per condition, for the general population, and $155 for Medicare beneficiaries.  
  • National health spending growth is projected to slow from 6.9% in 2005 to 6.8% in 2006, which marks the 4th consecutive year of a slowing trend.